- Home
- TARS vs SBET Comparison
TARS vs SBET Comparison
Compare TARS & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- SBET
- Stock Information
- Founded
- TARS 2016
- SBET 1995
- Country
- TARS United States
- SBET United States
- Employees
- TARS N/A
- SBET N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- SBET Computer Software: Prepackaged Software
- Sector
- TARS Health Care
- SBET Technology
- Exchange
- TARS Nasdaq
- SBET Nasdaq
- Market Cap
- TARS 2.8B
- SBET 2.4B
- IPO Year
- TARS 2020
- SBET 1997
- Fundamental
- Price
- TARS $77.39
- SBET $9.87
- Analyst Decision
- TARS Strong Buy
- SBET Strong Buy
- Analyst Count
- TARS 7
- SBET 3
- Target Price
- TARS $69.86
- SBET $31.00
- AVG Volume (30 Days)
- TARS 461.9K
- SBET 10.9M
- Earning Date
- TARS 11-04-2025
- SBET 11-12-2025
- Dividend Yield
- TARS N/A
- SBET N/A
- EPS Growth
- TARS N/A
- SBET N/A
- EPS
- TARS N/A
- SBET N/A
- Revenue
- TARS $366,100,000.00
- SBET $13,106,030.00
- Revenue This Year
- TARS $139.46
- SBET $78,838.41
- Revenue Next Year
- TARS $49.91
- SBET N/A
- P/E Ratio
- TARS N/A
- SBET N/A
- Revenue Growth
- TARS 182.44
- SBET 239.01
- 52 Week Low
- TARS $38.51
- SBET $2.26
- 52 Week High
- TARS $78.76
- SBET $124.12
- Technical
- Relative Strength Index (RSI)
- TARS 66.65
- SBET 29.92
- Support Level
- TARS $70.84
- SBET $10.70
- Resistance Level
- TARS $78.76
- SBET $11.27
- Average True Range (ATR)
- TARS 3.29
- SBET 0.86
- MACD
- TARS 0.35
- SBET -0.07
- Stochastic Oscillator
- TARS 88.54
- SBET 2.16
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.